Showing results (101-110 of 207) with videos related to

Sort By:
Pageof 21
Musculoskeletal Surgery|September 9, 2024
One type of graft for reconstruction of the ACL does not suit all patients based on their characteristics and sports: a scoping reviewJ M Reinerink, T Vendrig, M N J Keizer, et al.
Cancer Letters|March 1, 1988
Combined effects of bromovinyldeoxyuridine and fractionated or continuous administration of 5-fluorouracil in P388 leukemia-bearing miceH J Keizer, R Pauwels, W Landuyt, et al.
Biopharmaceutics & Drug Disposition|December 18, 2001
Distribution of ifosfamide and metabolites between plasma and erythrocytesT Kerbusch, V M Herben, M J Jeuken, et al.
Antimicrobial Resistance and Infection Control|August 8, 2020
Finding the match between healthcare worker and expert for optimal audit and feedback on antimicrobial resistance prevention measuresJ Keizer, N Beerlage-De Jong, N Al Naiemi, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 16, 2001
Influence of dose and infusion duration on pharmacokinetics of ifosfamide and metabolitesT Kerbusch, R A Mathôt, H J Keizer, et al.
Ecotoxicology (London, England)|September 13, 2014
Potential risk of biochar-amended soil to aquatic systems: an evaluation based on aquatic bioassaysA C Bastos, M Prodana, N Abrantes, et al.
Computer Methods and Programs in Biomedicine|July 15, 2010
Piraña and PCluster: a modeling environment and cluster infrastructure for NONMEMRon J Keizer, Michel van Benten, Jos H Beijnen, et al.
Carcinogenesis|July 1, 1992
Determination of N7-methylguanine in DNA of white blood cells from cancer patients treated with dacarbazineJ H van Delft, A M van den Ende, H J Keizer, et al.
The AAPS Journal|June 1, 2012
Performance of methods for handling missing categorical covariate data in population pharmacokinetic analysesRon J Keizer, Anthe S Zandvliet, Jos H Beijnen, et al.
Investigational New Drugs|June 1, 2011
Two-stage model-based design of cancer phase I dose escalation trials: evaluation using the phase I program of barasertib (AZD1152)Ron J Keizer, Anthe S Zandvliet, Jos H Beijnen, et al.
Pageof 21